arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

download Export Data

Incannex Healthcare Inc.

IXHL

$2.24 ▼ -0.25 (-10.04%) at close

7 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Incannex Healthcare Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $26.1M

Dividend Yield —

Revenue Growth N/M

Op. Margin —

ROIC -34.2% ↗

FCF / Share $-1.10 ↗

Trailing P/E —

Price / Book 0.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-19.30M

↑ +58.8% —

FCF / Share Free cash flow per share

$-1.10

↑ +89.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗	FY 2020 Jun 30, 2020 20-F ↗
Revenue Growth YoY (%)	N/M	616.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7608%)	—	—	—	—	—
EPS Growth YoY (%)	95.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-17.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	65.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	58.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-154.0% Weak ↓ Weak Declining Year-over-year change in net income	62.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-227.5% Weak ↓ Weak Declining Year-over-year change in net income	-31.0% Weak Weak Year-over-year change in net income	-142.1% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	89.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	63.9% Excellent Excellent Year-over-year change in free cash flow	-38.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗	FY 2020 Jun 30, 2020 20-F ↗
Effective Tax Rate (%) (%)	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
FCF / Net Income (x)	0.67x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.27x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗	FY 2020 Jun 30, 2020 20-F ↗
Return on Invested Capital (%)	-34.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-177.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-268.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-188.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-31.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-116.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-176.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-208.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-28.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-291%)	—	-164.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1197%)	-234.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1663%)	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗	FY 2020 Jun 30, 2020 20-F ↗
Net Debt (USD)	$-67.71M	$-15.04M	$-5.86M	$-22.12M	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗	FY 2020 Jun 30, 2020 20-F ↗
Revenue per Share (USD)	$0.00	$0.07	$0.02	—	—	—	—
Basic EPS, GAAP (USD)	$-1.66	$-40.82	$-34.85	$-100.61	—	—	—
Free Cash Flow per Share (USD)	$-1.10	$-10.90	$-30.22	$-21.79	—	—	—
Book Value per Share (USD)	$5.37	$2.07	$19.27	$39.76	—	—	—
Tangible Book Value per Share (USD)	$5.37	$2.07	$19.27	$39.76	—	—	—
Basic Weighted Avg Shares (shares)	11.66M	1.15M	533,423	507,695	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗	FY 2020 Jun 30, 2020 20-F ↗
Working Capital (USD)	$71.33M	$12.98M	$10.58M	$20.45M	—	—	—
Total Equity (USD)	$67.37M	$13.39M	$11.22M	$20.82M	—	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 20-F ↗	FY 2021 Jun 30, 2021 20-F ↗	FY 2020 Jun 30, 2020 20-F ↗
Sales/Revenue/Turnover (USD)	$0.00	$86.00K	$12.00K	—	—	—	—
Depreciation Expense (USD)	$240.00K	$246.00K	$103.00B	$23.00M	—	—	—
Net Income, GAAP (USD)	$-19.30M	$-46.88M	$-18.46M	$-48.81M	$-14.90M	$-11.37M	$-4.70M
Operating Cash Flow (USD)	$-12.87M	$-12.51M	$-15.85M	$-10.75M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 18 quarters

Incannex Healthcare Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IXHL with peers